Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
Hugel Inc (145020 KS)
Watchlist
52
Analysis
Health Care
•
South Korea
Hugel, Inc. is a Bio-pharmaceutical company that focuses on developing beauty/cosmetics related products. The Company's main products include botulinum toxin and fillers.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
16 Nov 2017 14:57
KOSDAQ's Bullish Run - Main Drivers & Stocks to Pick
KOSDAQ is getting really hot. Over the past three months, KOSDAQ index climbed 22.89% by 145.31 points from 642.11 on Aug 17 to 780.22 today on Nov...
Sanghyun Park
Follow
694 Views
Share
bullish
•
SK Telecom
•
08 Oct 2017 19:05
SK Group Restructuring - Local Institutions Are Already Making A Move
We are now seeing a very interesting move from Korea's local institutions on those SK Group restructuring stocks. Last week, to be specific from...
Sanghyun Park
Follow
392 Views
Share
bullish
•
Thematic (Sector/Industry)
•
05 Oct 2017 14:59
Foreign Investors Vs. Local Institutions in Korean Stock Market - Who Is Right?
Last month, foreign investors went on a buying spree in the Korea's second largest stock market, KOSDAQ. In contrast, they went on a selling spree...
Sanghyun Park
Follow
1.1k Views
Share
bullish
•
Hugel Inc
•
10 Aug 2017 05:21
Hugel: Botulinum Injects Sales from Exports
Strong sales momentum, low price volatility versus the Korean market,and improving asset turnover relative to its sector In April, Hugel signed a...
A. Stotz Investment Research
Follow
354 Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 Dec 2016 00:24
MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry
Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...
Nomadic Equity
4.1k Views
Share
First
Previous
6
7
8
9
10
11
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x